ConductScience.org, home

Paper40980916

Comparison of different colistin sulfate regimens for carbapenem-resistant gram-negative bacteria pneumonia in neurocritical care patients: a retrospective cohort study.

Zeng Q and 8 others. Antimicrob Agents Chemother, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Comparison of different colistin sulfate regimens for carbapenem-resistant gram-negative bacteria pneumonia in neurocritical care patients: a retrospective cohort study. Papers, record 40980916. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40980916

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of different colistin sulfate regimens for carbapenem-resistant gram-negative bacteria pneumonia in neurocritical care patients: a retrospective cohort study.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2025
PubMed
Publication types
Journal Article, Comparative Study
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-05-16
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zeng QQianhttps://orcid.org/0000-0002-5594-6747
2Huang HHuawei
3Lu JJiaqi
4Wu LLei
5Zhang SShaolan
6Zhao JJingwei
7Chen GGuangqiang
8Li HHonglianghttps://orcid.org/0000-0001-5543-7726
9Shi GGuangzhihttps://orcid.org/0009-0004-4690-6235

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ColistinMajor topic
Anti-Bacterial AgentsMajor topic
CarbapenemsMajor topic
Gram-Negative BacteriaMajor topic
Pneumonia, BacterialMajor topic
Gram-Negative Bacterial InfectionsMajor topic
Humans
Male
Female
Retrospective Studies
Middle Aged
Aged
Intensive Care Units
Critical Care
Cross Infection

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2022-N-09Multidisciplinary Integrated Research Project of China International Medical FoundationPubMed
2100199Key Clinical Specialty Project of Beijing Municipal Health CommissionPubMed
PX2023021Beijing Municipal Administration of Hospitals Incubating ProgramPubMed

Source PubMed

Download CSV of grants

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127418577Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.Clin Infect Dis2016https://conductscience.org/library/papers/27418577PubMed
228575278Pharmacokinetics of nebulized colistin methanesulfonate in critically ill patients.J Antimicrob Chemother2017https://conductscience.org/library/papers/28575278PubMed
34356004Prevention of gram-negative bacillary pneumonia using aerosol polymyxin as prophylaxis. I. Effect on the colonization pattern of the upper respiratory tract of seriously ill patients.J Clin Invest1973https://conductscience.org/library/papers/4356004PubMed
428669836Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.Int J Antimicrob Agents2018https://conductscience.org/library/papers/28669836PubMed
527160031Colistin Use in Patients With Reduced Kidney Function.Am J Kidney Dis2016https://conductscience.org/library/papers/27160031PubMed
632284036Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019).Emerg Microbes Infect2020https://conductscience.org/library/papers/32284036PubMed
737120926Nebulized colistin as the adjunctive treatment for ventilator-associated pneumonia: A systematic review and meta-analysis.J Crit Care2023https://conductscience.org/library/papers/37120926PubMed
831362898Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer.Eur Urol2019https://conductscience.org/library/papers/31362898PubMed
931364081Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Polymyxins: Implications for Therapeutic Use.Adv Exp Med Biol2019https://conductscience.org/library/papers/31364081PubMed
1025493971The role of aerosolized colistin in the treatment of ventilator-associated pneumonia: a systematic review and metaanalysis.Crit Care Med2015https://conductscience.org/library/papers/25493971PubMed
1125445887
Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.
J Infect2015https://conductscience.org/library/papers/25445887PubMed
1233627412Rescuing the Last-Line Polymyxins: Achievements and Challenges.Pharmacol Rev2021https://conductscience.org/library/papers/33627412PubMed
1324754731Nebulized colistin for non-cystic fibrosis bronchiectasis: déjà vu all over again?Am J Respir Crit Care Med2014https://conductscience.org/library/papers/24754731PubMed
1426607337Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis.Int J Antimicrob Agents2015https://conductscience.org/library/papers/26607337PubMed
1531802860Nebulized Colistin And Continuous Cyclic Azithromycin In Severe COPD Patients With Chronic Bronchial Infection Due To Pseudomonas aeruginosa: A Retrospective Cohort Study.Int J Chron Obstruct Pulmon Dis2019https://conductscience.org/library/papers/31802860PubMed
1633832018[Multi-disciplinary expert consensus on the optimal clinical use of the polymyxins in China].Zhonghua Jie He He Hu Xi Za Zhi2021https://conductscience.org/library/papers/33832018PubMed
1728458172Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii.J Crit Care2017https://conductscience.org/library/papers/28458172PubMed
1820558557Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration.Chest2010https://conductscience.org/library/papers/20558557PubMed
1936105229Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients.Front Pharmacol2022https://conductscience.org/library/papers/36105229PubMed
2020397007Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa.Intensive Care Med2010https://conductscience.org/library/papers/20397007PubMed

See all 41 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42572787Comparative Effectiveness of Colistin Sodium versus Polymyxin B Sulfate Against CR-GNB: A Retrospective Cohort Study.Infect Drug Resist2026https://conductscience.org/library/papers/42572787

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40980916

GET https://conductscience.org/api/papers/v1/40980916/references?page=2